Integra Flowable Wound Matrix Catalog No: FWD301 Product Usage: Integra Flowable Wound Matri...
FDA Device Recall #Z-1338-2019 — Class II — March 31, 2019
Recall Summary
| Recall Number | Z-1338-2019 |
| Classification | Class II — Moderate risk |
| Date Initiated | March 31, 2019 |
| Status | Terminated |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | Integra Limited |
| Location | Plainsboro, NJ |
| Product Type | Devices |
| Quantity | 274 units |
Product Description
Integra Flowable Wound Matrix Catalog No: FWD301 Product Usage: Integra Flowable Wound Matrix is indicated for the treatment of tunneling and/or undermined wounds including: surgical wounds (donor sites/grafts, post-Moh s surgery, post-laser surgery, podiatric, wound dehiscence) and diabetic ulcers of both partial and full-thickness varieties. The device is intended for one-time use.
Reason for Recall
Stability did not meet acceptance criteria for visual appearance during mixing and force vs. displacement at 6 months
Distribution Pattern
Worldwide Distribution - US Nationwide Foreign; Peru, Ecuador, Columbia, Brazil
Lot / Code Information
Lot Code: 2991332
Other Recalls from Integra Limited
| Recall # | Classification | Product | Date |
|---|---|---|---|
| Z-1089-2019 | Class II | Integra bioBLOCK Resorbable subtaler Implant, 1... | Mar 1, 2019 |
| Z-1091-2019 | Class II | Integra bioBLOCK Resorbable subtaler Implant, 1... | Mar 1, 2019 |
| Z-1090-2019 | Class II | Integra bioBLOCK Resorbable subtaler Implant, 1... | Mar 1, 2019 |
| Z-0117-2014 | Class II | Brand Names: Integra¿ Camino 110-4 Intracranial... | Sep 10, 2013 |
| Z-2056-2013 | Class II | Integra Leyla Ball Joint Clamp, also as include... | Jul 17, 2013 |
Frequently Asked Questions
Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.
Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.
Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.
What Should You Do?
Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.